Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Next Generation Sequencing in the Clinic Asia Summit 2017

Dennis Huang's Biography



Dennis Huang, Product Manager, Thermo Fisher Scientific

Dennis is the product manager of Thermo Fisher Scientific, providing NGS/qPCR technical consultation for researchers in Taiwan. Dennis received his master degree from National Yang-Ming University, institute of microbiology and immunology. Before joining the Thermo Fisher Scientific, Dennis worked as a technical application specialist for Cold Spring Biotech and was responsible for lab automation integration, liquid biopsy analysis technology. From 2016, Dennis joined Thermo Fisher Scientific LSG (Life Science Solution Group) and is now working on the oncology business development in Taiwan. He is passionate about implementing new technology in the field in order to improve the patient’s welfare and safety.

Dennis Huang Image

Monitor Immune Responses in Tumor Microenvironment by Next Generation Sequencing

Thursday, 30 November 2017 at 15:30

Add to Calendar ▼2017-11-30 15:30:002017-11-30 16:30:00Europe/LondonMonitor Immune Responses in Tumor Microenvironment by Next Generation SequencingNext Generation Sequencing in the Clinic Asia Summit 2017 in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com

The composition of tumor microenvironment (TME) is highly variable and complex, it often found related to drug response, such as immune checkpoint or CAR-T therapy. How to characterize the TME in an efficient way become more and more important. Besides tumor cells, certain types of cells from immune system plays a critical role when fighting cancer, for example, dendritic cells (DCs) and T cells are capable of activating anti-tumor responses. However, certain cancer cells may induce an immunosuppressive reaction in TME and then weaken the anti-cancer responses even one is treated with immunotherapy. During the session, we will be discussing our latest NGS panel Oncomine Immune Response Research Assay and Ion Ampliseq Immune Repertoire Assay, which can facilitate the research to understand the TME, in order to help resolves the issues and even to predict the responses to immunotherapies.


Add to Calendar ▼2017-11-30 00:00:002017-11-30 00:00:00Europe/LondonNext Generation Sequencing in the Clinic Asia Summit 2017Next Generation Sequencing in the Clinic Asia Summit 2017 in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com